The SAMBA Platform
Following the proven success of SAMBA II in global HIV monitoring and the NHS response to the Covid-19 pandemic, SAMBA III expands the boundaries of rapid near-patient testing
Next-Generation Diagnostics: SAMBA III
- Lab-Quality Accuracy: Fast turnaround times without compromising precision
- Fully Flexible: Easily scales across a broad menu of infectious diseases
- Seamlessly Connected: Automated results to integrate with LIMS
Why Choose SAMBA III?
- SAMBA III redefines near-patient diagnostics by pairing laboratory-grade performance with an effortless ~30-minute workflow
- With under 60 seconds of hands-on time, enveloped viral inactivation, and zero cold-chain storage requirements, SAMBA III simplifies testing anywhere—from central labs to remote clinics
- Detect up to 15 targets from a single sample, gain actionable insights with CT values available for information purposes, and automatically sync results directly to your LIMS via the SAMBA Hub
- Fast, safe, and built for real-world healthcare
What Makes SAMBA III Different?
- Smarter Amplification: Uses up to three independent amplification tubes per kit to eliminate target competition and interference—outperforming conventional multiplex assays
- Superior Precision: Delivers enhanced analytical sensitivity and specificity for fast, uncompromising clinical confidence
- Flexible Syndromic Testing: Replaces rigid, fixed panels with adaptable testing tailored directly to the patient’s symptoms
- Future-Proof Scalability: Built on an adaptable platform designed for rapid assay expansion and emerging pathogen response
